Aphria Announces Closing of Bought Deal Financing
Aphria Inc. (TSX: APH) (OTCQB:  APHQF) is pleased to announce it has closed its short form prospectus offering, on a bought deal basis, including the exercise in full of the underwriters’ over-allotment option. A total of 21,835,510 common shares of the Company were sold at a price of $11.85 per Share, for aggregate... Read more
From CFN: Choom and Aurora Team Up for Canadian Retail Cannabis
With the date now set for Canada to fully legalize adult-use cannabis on October 17, 2018, it may be useful for investors to review how companies are positioned for the event. There are a lot of moving parts at this point, with wholesale supply concerns, branding and advertising rules,... Read more
U.S. Sen. Chuck Schumer Files Marijuana Decriminalization Bill
Deeply conservative Oklahoma became the 30th U.S. state to legalize medical marijuana after voters approved a ballot initiative by a 57-43 margin on June 26. The move signaled new inroads among Bible Belt constituencies, where, by and large, state policies have restricted medical cannabis use to hemp-derived CBD products... Read more
Marijuana Stocks & The Next Big Bid For Market Domination
There’s no denying it anymore. The legal marijuana business is booming and the first G7 country has now legalized cannabis both recreationally and medicinally. That’s right Canada’s June 7 vote sealed the deal for something that could quickly become the biggest industry boom since the industrial age! A little... Read more
Namaste Technologies Inc. (NXTTF) signs Master Services Agreement with Australian-based YPB
Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV:N.V)(M5BQ.F)(NXTTF) is pleased to announce signing of a Master Services Agreement (the “Agreement”) with YPB Group Ltd. (“YPB”)(YPB.AX), an Australian based product verification and customer engagement company. Namaste has identified the need for its global customers to have confidence in the products... Read more
Cannabis Production Facility Celebrates Grand Opening
Justin Gover, the CEO of GW Pharmaceuticals, told CNBC his company’s new drug will pave the way for other medications derived from marijuana. On Monday, the Food and Drug Administration approved the company’s new epilepsy drug, Epidiolex, the first cannabis-based drug the U.S. regulator has approved. “This is an approval, not... Read more
Marijuana Stocks Newsletter – Wednesday June 27, 2018
Good Morning & Happy Wednesday! – 6/27/2018! What’s The Next Big Wave For MJ?With Canada’s recreational MJ industy recently being legalized, cannabis stocks are captivating the markets. And if you’ve been following along, you would have already seen that one particular MJ Stock could be making a new trend... Read more
The Biggest Cannabis Stocks in the Industry Continue to Grow
The marijuana market has continued to show a large amount of promise over the course of the past year or so. With new legislation going into place around North America and the world, it seems as though the cannabis industry is just now getting started. Momentum during the past... Read more
Choom and Aurora Team Up for Canadian Retail Cannabis
Robin Lefferts June 27th, 2018 Exclusive, News, Top News With the date now set for Canada to fully legalize adult-use cannabis on October 17, 2018, it may be useful for investors to review how companies are positioned for the event. There are a lot of moving parts at... Read more
CROP Signs Italy Joint Venture to Develop 522,000 Square Feet of CBD Dominant Cannabis Light Farms and the Retrofit and Development of a GMP Processing Facility
VANCOUVER, British Columbia, June 27, 2018 (GLOBE NEWSWIRE) — CROP Infrastructure Corp. (CSE:CROP) (OTCMKTS:CRXPF) (“CROP” or the “Company”) announces it has entered into a joint venture agreement whereby CROP will own 30% under the name of Xhemplar to develop a 522,000 square foot project in the North-Eastern region of Italy. The joint venture and its... Read more



( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )